Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-12

Clinical Trial Update: Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intraarticular dextrose prolotherapy for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextrose prolotherapy (dextrose prolotherapy)

Snippet

Sponsor: Mayo Clinic | Conditions: Knee Osteoarthritis | Phase 2 | Status: COMPLETED